Stay updated with breaking news from இரட்டை குருட்டு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
23 books to read in 2021 Today s best articles Daily business briefing Solving COVID newsletter It has been nearly a year now since most of us have enjoyed a book in any of the usual places: a coffee shop, on a commute, in an airplane, on a beach. But that hasn t stopped people from reading â in fact, the opposite. Speaking personally, 2020 made me extra grateful for all the moments I spent with paper and ink, away from yet another screen containing no good news. Now we seem on the cusp of what is hopefully the beginning of the end, and it becomes possible again to imagine reading books in places like coffee shops or on transcontinental flights. But our to-be-read piles might be starting to look a little shorter after all those months in quarantine. ....
Everyone’s Talking About. No One Is Talking About This (Bloomsbury, February) by Patricia Lockwood, the ‘Poet Laureate of Twitter’, is set to be one of 2021’s buzziest books: a riveting novel about the collision between real and online life. Meanwhile, the sexy and absurdly readable Luster by Raven Leilani (Picador, January) is an unflinching interrogation of racial and sexual politics that carries ringing endorsements from Zadie Smith and Candice Carty-Williams. Rahul Raina’s How To Kidnap The Rich (Little Brown, May) has already been optioned by HBO: a Delhi-set, reality TV-based literary crime crossover, it will appeal to fans of Parasite and Crazy Rich Asians. ....
Interim Analysis of Recardio s Phase II Clinical Trial Published in European Heart Journal Recardio Inc., a life science company developing regenerative therapies for cardiovascular diseases, announced that its positive results of the interim analysis of Recardio s Phase II clinical trial in AMI were published in the latest release of the European Heart Journal. The current version of the journal relates to the presentation during the 2020 Congress of the European Society of Cardiology. News provided by Share this article Share this article SAN FRANCISCO, Dec. 17, 2020 /PRNewswire/ Entitled Randomized, Double Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction: rationale, design and first interim analysis , the publication provides a first insight into patient outcomes of the trial that is currently ongoing in multiple centers. Patients included in this trial experie ....